Article

CIBA Vision to distribute BioVision microkeratome

CIBA Vision Corp. (Booth #802) has signed a distribution agreement withSwitzerland-based BioVision AG to distribute BioVision's patented blade-cartridgemicrokeratome. CIBA Vision will market the device under the name CenturionSES.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Related Content
Galimedix Therapeutics initiates phase 1 trial of oral GAL-101
December 6th 2024

Galimedix Therapeutics initiates phase 1 trial of oral GAL-101

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Cambium Bio completes funding to help advance dry eye disease treatment
December 5th 2024

Cambium Bio completes funding to help advance dry eye disease treatment

Robert Chang, MD, discusses the impact of large language models on glaucoma care and AI in ophthalmology
November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

Risk factors for cataracts in patients with diabetes mellitus
December 5th 2024

Risk factors for cataracts in patients with diabetes mellitus

VivaVision Biotech reports positive Phase 2 trial results of VVN461 for postoperative inflammation treatment following cataract surgery
December 5th 2024

VivaVision Biotech reports positive Phase 2 trial results of VVN461 for postoperative inflammation treatment following cataract surgery

© 2024 MJH Life Sciences

All rights reserved.